QR Kod

Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS

Atazanavir (ATZ) presents poor brain availability when administered orally, which poses a major hurdle in its use as an effective therapy for the management of NeuroAIDS. The utilization of nanostructured lipid carriers (NLCs) in conjunction with the premeditated use of excipients can be a potential...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Saif Ahmad Khan, Saleha Rehman, Bushra Nabi, Ashif Iqubal, Nida Nehal, Usama A. Fahmy, Sabna Kotta, Sanjula Baboota, Shadab Md, Javed Ali
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2020-11-01
Seri Bilgileri:Pharmaceutics
Konular:
atazanavir
nanostructured lipid carriers
neuroAIDS
brain targeting
histopathology
Online Erişim:https://www.mdpi.com/1999-4923/12/11/1059
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller